No Data
Stem Inc, MDNT and others [Emerging Markets Press Release]
Acquired and subordinated the stock of Swaying Wind, who operates the WOLVES animal hospital. Started manufacturing specific cell products ('S-DSC') for hair regeneration under contract with MDNT. Registered patents (China) for peptides related to the peripheral peptides of LedaSemchidot (HMGB1 fragment peptide) at Stemlim Regenerative Induction Medicine. Massive exercise of Fanpep's 11th subscription rights (with modification clause for exercise price) to issue 0.67 million 4,000 shares starting from the first day.
Balmuda: Interim Report - 22nd period (2024/01/01 - 2024/06/30)
BALMUDA Inc. Reports Mixed Mid-Year Financials
Balmuda: Earnings conference materials for the second quarter (interim period) of December 2024.
Balmuda: Announcements of individual stocks regarding the revision of financial estimates for the consolidated results for the fiscal year ending December 2024.
Balmuda: Financial results announcement for the second quarter (interim) of the fiscal year ending December 2024 under Japanese accounting standards (consolidated).
No Data
